Fig. 4From: A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinomaROC curves show the sensitivity and specificity of the five-DNA methylation signature and other known biomarkers in predicting the OS of patientsBack to article page